News ItemNational Bioeconomy Blueprint

June 1, 2012 – 

Interesting reading for those in the biotech community – the blueprint outlines the federal bioeconomy objectives and provides detail on the emerging bioeconomy. The report is attached for your convenience.

Federal objectives are: strengthening research and development, getting products from lab to market, reducing regulatory barriers, developing a workforce for the industry and fostering partnerships.

As part of our effort at NMBio to provide relevant programs for our members, we have had presentations from various speakers on topics that fit in with the above objectives, though not by design, but by reflecting on issues our members raise.

Please visit our events page for a list of upcoming programs.

 

Share:
Novo Norodisk

Novo Norodisk

Southwest Labs

Southwest Labs

UPS

UPS

Curia Global

Curia Global

Aerotek

Aerotek

Emera

Emera

Amgen

Amgen

STC UTM

STC UTM

Arrowhead Center

Arrowhead Center

New Mexico Consortium

New Mexico Consortium

Bio

Bio

Burrell College of Osteopathic Medicine

Burrell College of Osteopathic Medicine

Bristol Myers Squibb

Bristol Myers Squibb

Sandia National Laboratories

Sandia National Laboratories

Colliers

Colliers